Stefan Ogrodzinski

CEO Biostatus Ltd

Stefan received his BSc (Hons) in Toxicology and Pharmacology from The School of Pharmacy, University of London, in 1987 and his MBA from De Montfort University in 1999. Stefan’s career has spanned the pharmaceutical industry, the healthcare sector, the voluntary sector and the educational sector, giving 20 years of sales, marketing, management and directorship experience.

In 2000, Stefan founded Biostatus and since that time has led the company as its CEO.

Stefan is also a Director of Medilink East Midlands Limited, BioCity Nottingham Limited, BioSuspensions Limited, BioTherics Limited, OncoTherics Limited, nanoTherics Limited, a member of the third mission committee at the Cardiff Institute of Tissue Engineering and Repair, a member of the advisory panel for the Astra Zeneca Post Doctoral Training Centre at Nottingham University and Senior Partner at Ogrodzinski Consultants.